cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.48370/ofd/olulzs
title: Szczawik żółty (Oxalis fontana Bunge), 2912

description: Herbarium
DOI: 10.48370/ofd/pvgpt6/idwgru
title: HMW_Oxalis_fontana_Bunge_H_3758.jpg

description: :unav
DOI: 10.48370/ofd/pvgpt6
title: Szczawik żółty (Oxalis fontana Bunge), 3758

description: Herbarium
DOI: 10.48370/ofd/0bgsa6/gtpdzc
title: HMW_Oxalis_fontana_Bunge_H_3701.jpg

description: :unav
DOI: 10.48370/ofd/0bgsa6
title: Szczawik żółty (Oxalis fontana Bunge), 3701

description: Herbarium
DOI: 10.48370/ofd/6bhedt/ks4mag
title: HMW_Oxalis_fontana_Bunge_H_0989.jpg

description: :unav
DOI: 10.48370/ofd/6bhedt
title: Szczawik żółty (Oxalis fontana Bunge), 989

description: Herbarium
DOI: 10.48370/ofd/eoagc7/hi9uot
title: HMW_Oxalis_fontana_Bunge_H_4068.jpg

description: :unav
DOI: 10.48370/ofd/eoagc7
title: Szczawik żółty (Oxalis fontana Bunge), 4068

description: Herbarium
DOI: 10.48370/ofd/2cjtmr/uwvvh7
title: HMW_Oxalis_fontana_Bunge_H_3893.jpg

description: :unav
DOI: 10.48370/ofd/2cjtmr
title: Szczawik żółty (Oxalis fontana Bunge), 3893

description: Herbarium
DOI: 10.48370/ofd/hdiias/njvz8u
title: HMW_Oxalis_fontana_Bunge_H_3262.jpg

description: :unav
DOI: 10.48370/ofd/hdiias
title: Szczawik żółty (Oxalis fontana Bunge), 3262

description: Herbarium
DOI: 10.48370/ofd/b7xzce/g758u7
title: HMW_Oxalis_fontana_Bunge_H_0590.jpg

description: :unav
DOI: 10.48370/ofd/b7xzce
title: Szczawik żółty (Oxalis fontana Bunge), 590

description: Herbarium
DOI: 10.48370/ofd/lwxvck/3umwtr
title: HMW_Papaver_dubium_L._H_8946.jpg

description: :unav
DOI: 10.48370/ofd/lwxvck
title: Mak wątpliwy (Papaver dubium L.), 8946

description: Herbarium
DOI: 10.48370/ofd/juihdt/9y1g0t
title: HMW_Papaver_dubium_L._H_1221.jpg

description: :unav
DOI: 10.48370/ofd/juihdt
title: Mak wątpliwy (Papaver dubium L.), 1221

description: Herbarium
DOI: 10.48370/ofd/ntylkz/yhkfdu
title: HMW_Papaver_dubium_L._H_5668.jpg

description: :unav
DOI: 10.48370/ofd/ntylkz
title: Mak wątpliwy (Papaver dubium L.), 5668

description: Herbarium
DOI: 10.48370/ofd/3cqf1q/5aitf4
title: HMW_Papaver_dubium_L._H_3464.jpg

description: :unav
DOI: 10.48370/ofd/3cqf1q
title: Mak wątpliwy (Papaver dubium L.), 3464

description: Herbarium
DOI: 10.48370/ofd/fxuyqc/kayrqg
title: HMW_Papaver_dubium_L._H_0772.jpg

description: :unav
DOI: 10.48370/ofd/fxuyqc
title: Mak wątpliwy (Papaver dubium L.), 772

description: Herbarium
DOI: 10.25550/2-hw0p
title: My test dataset 1

description: this data etc...
DOI: 10.25934/00005589.0
title: Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Bevacizumab, Temozolomide and Radiotherapy, Followed by Bevacizumab and Temozolomide Versus Placebo, Temozolomide and Radiotherapy Followed by Placebo and Temozolomide in Patients With Newly Diagnosed Glioblastoma'

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00005589.1
title: IPD datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Bevacizumab, Temozolomide and Radiotherapy, Followed by Bevacizumab and Temozolomide Versus Placebo, Temozolomide and Radiotherapy Followed by Placebo and Temozolomide in Patients With Newly Diagnosed Glioblastoma' and research request: 'Evaluation of Differences in Trial and Non-Trial Patients and Leveraging of External Data for More Efficient Clinical Trial Designs in Newly Diagnosed Glioblastoma'

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.6084/m9.figshare.16592879
title: Data Files

description: Raw data in Excel.
DOI: 10.6084/m9.figshare.16592879.v1
title: Data Files

description: Raw data in Excel.
DOI: 10.6084/m9.figshare.16592819
title: A Chickpea Pan-genome

description: A chickpea pan-genome to describe genomic diversity across cultivated chickpea and its wild progenitor accessions.
DOI: 10.5281/zenodo.5497635
title: Monocercomonoides exilis genome files

description: The genome annotation files for M. exilis genome, based on nanopore sequencing. The annotation was further polished using long-read transcriptomic data.
DOI: 10.5281/zenodo.5497634
title: Monocercomonoides exilis genome files

description: The genome annotation files for M. exilis genome, based on nanopore sequencing. The annotation was further polished using long-read transcriptomic data.
DOI: 10.6084/m9.figshare.16592900
title: sampledata.tar.gz

description: This is an example for testing the InDelGT integration pipeline.
DOI: 10.6084/m9.figshare.16592900.v1
title: sampledata.tar.gz

description: This is an example for testing the InDelGT integration pipeline.
DOI: 10.5519/qd.tf24xwyk
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (117 records)
DOI: 10.14469/hpc/8795
title: Compound 3a

description: Characterisation NMR data for compound 3a and associated ChemDraw structure
DOI: 10.14469/hpc/8796
title: Compound 4e

description: Characterisation NMR data for compound 4e and associated ChemDraw structure
DOI: 10.14469/hpc/8797
title: Compound 5a

description: Characterisation NMR data for compound 5a and associated ChemDraw structure
DOI: 10.14469/hpc/8798
title: Compound 5b

description: Characterisation NMR data for compound 5b and associated ChemDraw structure
DOI: 10.14469/hpc/8799
title: Compound 6b

description: Characterisation NMR data for compound 6b and associated ChemDraw structure
DOI: 10.14469/hpc/8800
title: Compound d2-[1]2

description: Characterisation NMR data for compound d2-[1]2 and associated ChemDraw structure
DOI: 10.14469/hpc/8801
title: Compound d-2

description: Characterisation NMR data for compound d-2 and associated ChemDraw structure
DOI: 10.14469/hpc/8802
title: Reaction between 6a + H2

description: Reactivity NMR data for reaction between 6a + H2 and associated scheme
DOI: 10.14469/hpc/8803
title: 13C-labelling experiment

description: Reactivity NMR data for reaction between [Pd(13CH3)2(κ2-TMEDA)] + 2 and associated scheme
DOI: 10.14469/hpc/8804
title: X-ray

description: Compiled X-ray data
DOI: 10.6084/m9.figshare.12852132
title: Insight into intermolecular interactions and hydration properties of biologically active amino acids in aqueous solutions of cefepime: volumetric, compressibility and viscometric studies

description: The measurement of density, speed of sound and viscosity of an amino acid and its dipeptide i.e., glycine and glycylglycine in aqueous solution of antibiotic drug cefepime has been carried out at various temperatures. The density and speed of sound data has been used to obtain partial molar volume(Vφo), partial molar expansion coefficient(∂Vφo∂T)p, second derivative(∂2Vφo∂T2)p, hydration number (ηH), isentropic compressibility(κs), partial molar isentropic compressibility(κφ,so), partial molar volume of transfer(ΔtrVφo) and partial molar isentropic compressibility of transfer(Δtrκφ,so). The viscosity data have been used to calculate the viscosity B–coefficients, its temperature derivative dB/dT, viscosity B–coefficient of transfer (ΔtrB) and various thermodynamic parameters of activation of viscous flow i.e.,Δμ1o*,Δμ2o*, ΔS2o* and ΔH2o* for amino acid/peptide in cefepime solutions. The dependence of these parameters upon concentration and temperature clearly suggests the role of amino acid/peptide and cefepime in solute-solvent interactions. The obtained results have been explained on the basis of competing pattern of interactions between the co-solute and solute in the studied ternary system in order to deduce important information regarding drug-amino acid/peptide interactions.
DOI: 10.6084/m9.figshare.12852132.v1
title: Insight into intermolecular interactions and hydration properties of biologically active amino acids in aqueous solutions of cefepime: volumetric, compressibility and viscometric studies

description: The measurement of density, speed of sound and viscosity of an amino acid and its dipeptide i.e., glycine and glycylglycine in aqueous solution of antibiotic drug cefepime has been carried out at various temperatures. The density and speed of sound data has been used to obtain partial molar volume(Vφo), partial molar expansion coefficient(∂Vφo∂T)p, second derivative(∂2Vφo∂T2)p, hydration number (ηH), isentropic compressibility(κs), partial molar isentropic compressibility(κφ,so), partial molar volume of transfer(ΔtrVφo) and partial molar isentropic compressibility of transfer(Δtrκφ,so). The viscosity data have been used to calculate the viscosity B–coefficients, its temperature derivative dB/dT, viscosity B–coefficient of transfer (ΔtrB) and various thermodynamic parameters of activation of viscous flow i.e.,Δμ1o*,Δμ2o*, ΔS2o* and ΔH2o* for amino acid/peptide in cefepime solutions. The dependence of these parameters upon concentration and temperature clearly suggests the role of amino acid/peptide and cefepime in solute-solvent interactions. The obtained results have been explained on the basis of competing pattern of interactions between the co-solute and solute in the studied ternary system in order to deduce important information regarding drug-amino acid/peptide interactions.
DOI: 10.14469/hpc/8805
title: Neutron data

description: Compiled neutron diffraction data
DOI: 10.14469/hpc/8969
title: Computational Coordinates

description: Compiled file containing optimised coordinates for all computationally calculated structures.
DOI: 10.6084/m9.figshare.16592825
title: Supplementary Material for: Comparison of NICE Guideline CG149 and the Sepsis Risk Calculator for the Management of Early-Onset Sepsis on the Postnatal Ward

description: <b><i>Introduction:</i></b> The NICE guideline CG149 has increased the number of well infants receiving antibiotics for suspected early-onset sepsis (EOS). The Kaiser Permanente sepsis risk calculator (SRC) has safely and dramatically reduced investigations and antibiotics for suspected EOS in the USA. This study evaluates the current management of suspected EOS against the NICE guideline CG149 and the SRC. <b><i>Methods:</i></b> This study is a prospective, multicentre, observational study across 13 neonatal units in London. Infants were born between June and August 2019 at ≥34 weeks gestation and commenced on antibiotics for suspected EOS and cared for on postnatal/transitional care wards. Data were prospectively recorded: risk factors, clinical indicators, investigations, and results. Outcome measures included the following: (1) incidence of EOS and (2) proportion of infants recommended for antibiotics by NICE versus theoretical application of SRC. <b><i>Results:</i></b> 1,066/8,856 (12%) infants on postnatal/transitional care wards received antibiotics, 7 of whom had a positive blood culture (group B <i>Streptococcus</i> = 6 and <i>Escherichia coli</i> = 1), making the EOS incidence 0.8/1,000 infants. Six hundred one infants had data for SRC analysis, which recommended “antibiotics” or “blood culture” for 130/601 (21.6%) infants using an EOS incidence of 0.5/1,000 versus 527/601 (87.7%) if NICE was applied. <b><i>Conclusions:</i></b> Currently, 12.0% of infants on postnatal/transitional care wards receive antibiotics for suspected EOS. The SRC could dramatically reduce antibiotic use, but further prospective studies are required to evaluate safety of SRC implementation.
DOI: 10.6084/m9.figshare.16592825.v1
title: Supplementary Material for: Comparison of NICE Guideline CG149 and the Sepsis Risk Calculator for the Management of Early-Onset Sepsis on the Postnatal Ward

description: <b><i>Introduction:</i></b> The NICE guideline CG149 has increased the number of well infants receiving antibiotics for suspected early-onset sepsis (EOS). The Kaiser Permanente sepsis risk calculator (SRC) has safely and dramatically reduced investigations and antibiotics for suspected EOS in the USA. This study evaluates the current management of suspected EOS against the NICE guideline CG149 and the SRC. <b><i>Methods:</i></b> This study is a prospective, multicentre, observational study across 13 neonatal units in London. Infants were born between June and August 2019 at ≥34 weeks gestation and commenced on antibiotics for suspected EOS and cared for on postnatal/transitional care wards. Data were prospectively recorded: risk factors, clinical indicators, investigations, and results. Outcome measures included the following: (1) incidence of EOS and (2) proportion of infants recommended for antibiotics by NICE versus theoretical application of SRC. <b><i>Results:</i></b> 1,066/8,856 (12%) infants on postnatal/transitional care wards received antibiotics, 7 of whom had a positive blood culture (group B <i>Streptococcus</i> = 6 and <i>Escherichia coli</i> = 1), making the EOS incidence 0.8/1,000 infants. Six hundred one infants had data for SRC analysis, which recommended “antibiotics” or “blood culture” for 130/601 (21.6%) infants using an EOS incidence of 0.5/1,000 versus 527/601 (87.7%) if NICE was applied. <b><i>Conclusions:</i></b> Currently, 12.0% of infants on postnatal/transitional care wards receive antibiotics for suspected EOS. The SRC could dramatically reduce antibiotic use, but further prospective studies are required to evaluate safety of SRC implementation.
DOI: 10.6084/m9.figshare.15094539.v4
title: SSRGT_ExampleData.tar.gz

description: SSRGT is an easy-to-use and powerful tool to genotype and SSR calling across a hybrid population with genome resequencing data. This is the test data of SSRGT.<br>
DOI: 10.5281/zenodo.5497655
title: Control Accuracy Measurement of a Mixed Reality Application for Digital Twin based Crane Operation

description: The dataset corresponds the measurement that was implemented on the control accuracy of a mixed reality application for a digital twin based crane. The dataset contains two CSV files, one "Target" ", which is the selected target positions, and one "Measurement results", which is the actual crane position after moving to the target position.
DOI: 10.5281/zenodo.5471601
title: Control Accuracy Measurement of a Mixed Reality Application for Digital Twin based Crane Operation

description: The dataset corresponds the measurement that was implemented on the control accuracy of a mixed reality application for a digital twin based crane. The dataset contains two CSV files, one "Target" ", which is the selected target positions, and one "Measurement results", which is the actual crane position after moving to the target position.
DOI: 10.6084/m9.figshare.15094539.v5
title: SSRGT_ExampleData.tar.gz

description: SSRGT is an easy-to-use and powerful tool to genotype and SSR calling across a hybrid population with genome resequencing data. This is the test data of SSRGT.<br>
DOI: 10.25646/9011
title: Tagesdaten-CSV aus dem DIVI-Intensivregister

description: Die Tagesdaten-CSV entspricht einem Auszug der Daten des DIVI-Intensivregisters. Die Datei enthält eine Aggregation der aktuellsten Meldungen pro Landkreis. Es werden die aktuell gemeldeten Anzahlen der COVID-19 Intensivfälle sowie die gemeldeten intensivmedizinischen Behandlungskapazitäten angezeigt. Die Tagesdaten-CSV liefert dabei ausschließlich einen Blick auf die Daten gemäß dem Stand des betrachteten Tages. Die Daten sind im situationsbedingten Kontext aufbereitet, damit sind verschiedene Tagesdaten-CSVs u.U. nicht direkt miteinander vergleichbar. Die aktuellsten Meldungen werden im gewählten Betrachtungszeitfenster über alle Meldebereiche und Standorte aufsummiert. Weitere Informationen sind zu finden unter https://www.intensivregister.de/#/faq
DOI: 10.5281/zenodo.5497621
title: Trusted World of Corona (TWOC) - WHO COVID-19 Case Report Form (CRF) Synthetic Data - FAIR

description: The synthetic dataset that models COVID-19 real world observations from WHO COVID-19 RAPID Version CRFs of hospitalized patients for the hypothesis under study, originally created by the TWOC project.
description: The synthetic dataset creation has been supported by funding from the ZonMW Health Holland under the Trusted World of Corona (TWOC) project number LSHM20070. The synthetic dataset is in CSV and RDF file formats.
DOI: 10.5281/zenodo.5497620
title: Trusted World of Corona (TWOC) - WHO COVID-19 Case Report Form (CRF) Synthetic Data - FAIR

description: The synthetic dataset that models COVID-19 real world observations from WHO COVID-19 RAPID Version CRFs of hospitalized patients for the hypothesis under study, originally created by the TWOC project.
description: The synthetic dataset creation has been supported by funding from the ZonMW Health Holland under the Trusted World of Corona (TWOC) project number LSHM20070. The synthetic dataset is in CSV and RDF file formats.
DOI: 10.5517/ccdc.csd.ccnf7hs
title: CCDC 608545: Experimental Crystal Structure Determination

description: Related Article: H.Takahashi|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc1zlg9b
title: CCDC 1834992: Experimental Crystal Structure Determination

description: Related Article: Abdul Ajees Abdul Salam, T Shilpa, Madan Shankar, Aseefhali Bankapur, Rajeev Sinha, Lalitha Simon, C. Santhosh|2021|CSD Communication|||
description: Related Article: Abdul Ajees Abdul Salam, Shilpa T, Madan Kumar S, Aseefhali Bankapur, Rajeev K.Sinha, Lalitha Simon, Santhosh Chidangil|2021|RSC Advances|11|20123|doi:10.1039/d1ra02245h
DOI: 10.5517/ccdc.csd.cc26slm7
title: CCDC 2049429: Experimental Crystal Structure Determination

description: Related Article: Weilong LIU|2021|CSD Communication|||
description: Related Article: Weilong Liu, Rémi Patouret, Sofia Barluenga, Michael Plank, Robbie Loewith, Nicolas Winssinger|2021|ACS Cent.Sci.|7|954|doi:10.1021/acscentsci.1c00056
DOI: 10.5517/ccdc.csd.cc280hvn
title: CCDC 2085861: Experimental Crystal Structure Determination

description: Related Article: Jianmei Han|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc280qqr
title: CCDC 2086074: Experimental Crystal Structure Determination

description: Related Article: Andrei S. Batsanov|2021|CSD Communication|||
DOI: 10.3886/e113718v1-95960
title: Replication data for: Economic Shocks and Crime: Evidence from the Brazilian Trade Liberalization

description: This paper studies the effect of changes in economic conditions on crime. We exploit the 1990s trade liberalization in Brazil as a natural experiment generating exogenous shocks to local economies. We document that regions exposed to larger tariff reductions experienced a temporary increase in crime following liberalization. Next, we investigate through what channels the trade-induced economic shocks may have affected crime. We show that the shocks had significant effects on potential determinants of crime, such as labor market conditions, public goods provision, and income inequality. We propose a novel framework exploiting the distinct dynamic responses of these variables to obtain bounds on the effect of labor market conditions on crime. Our results indicate that this channel accounts for 75 to 93 percent of the effect of the trade-induced shocks on crime.
DOI: 10.5281/zenodo.5497696
title: gwastro/subsolar-o3a-search: v1.0 data release

description: Results from the search for sub-solar mass black hole mergers using the O3 LIGO and Virgo data.
DOI: 10.5281/zenodo.5497695
title: gwastro/subsolar-o3a-search: v1.0 data release

description: Results from the search for sub-solar mass black hole mergers using the O3 LIGO and Virgo data.
DOI: 10.6084/m9.figshare.16592981
title: Expriement1 metadata and taxonomy tables

description: 16S microbiome of rats
DOI: 10.6084/m9.figshare.16592981.v1
title: Expriement1 metadata and taxonomy tables

description: 16S microbiome of rats
DOI: 10.6084/m9.figshare.16593014
title: Exoeriment 2 metadat taxonomy and unifrac tables

description: 16S microbiome of rats stool
DOI: 10.6084/m9.figshare.16593014.v1
title: Exoeriment 2 metadat taxonomy and unifrac tables

description: 16S microbiome of rats stool
DOI: 10.6084/m9.figshare.16592999
title: Supplementary Material for: Preimplantation Genetic Testing Prevented Intergenerational Transmission of X-Linked Alport Syndrome

description: <b><i>Background:</i></b> Alport syndrome (AS) is a hereditary renal basement membrane disease that can lead to end-stage renal disease in young adults. It can be diagnosed by genetic analysis, being mostly caused by mutations in <i>COL4A3</i>, <i>COL­4A4</i>, and <i>COL4A5</i>. To date, there is no radical cure for this disease. <b><i>Objectives:</i></b> The aim of this study was to avoid the transmission of AS within an affected family by selecting healthy embryos for uterine transfer. The embryos were identified by preimplantation genetic testing for monogenic disorders (PGT-M). <b><i>Methods:</i></b> We used next-generation sequencing (NGS) to identify mutations in the proband and his parents. The results of NGS were confirmed by Sanger sequencing. Targeted NGS combined with targeted single-nucleotide polymorphism haplotyping was used for the in vitro identification of <i>COL4A5</i> mutations in human embryos to prevent their intergenerational transmission. <b><i>Results:</i></b> The c.349_359delGGACCTCAAGG and c.360_361insTGC mutations in <i>COL4A5</i> were identified in a family affected by X-linked AS. Whole-genome sequencing by NGS with targeted haplotyping was performed on biopsied trophectoderm cells. A healthy baby was born after transfer of a single freeze-thawed blastocyst. <b><i>Conclusions:</i></b> The use of targeted NGS for identifying diagnostic markers combined with targeted haplotyping is an easy and efficient PGT-M method for preventing intergenerational transmission of AS.
DOI: 10.6084/m9.figshare.16594718
title: Supplementary Material for: Bioreactance Cardiac Output Trending Ability in Preterm Infants: A Single Centre, Longitudinal Study

description: <b><i>Introduction:</i></b> It is unknown whether bioreactance (BR) can accurately track cardiac output (CO) changes in preterm neonates. <b><i>Methods:</i></b> A prospective observational longitudinal study was performed in stable preterm infants (&lt;37 weeks) during the first 72 h of life. Stroke volume (SV) and CO, as measured by BR and transthoracic echocardiography, were compared. <b><i>Results:</i></b> The mean gestational age (GA) was 31.3 weeks and mean birth weight (BW) was 1,563 g. Overall, 690 measurements were analysed for trending ability by 4-quadrant and polar plots. For non-weight-indexed measurements, 377 (54.6%) lay outside the 5% exclusion zone, the concordance rate was poor (77.2%) with a high mean angular bias (28.6°), wide limits of agreement and a poor angular concordance rate (17.4%). Neither GA, BW nor respiratory support mode affected trending data. Patent ductus arteriosus, postnatal age, and CO level had variable effects on trending data. Trending data for 5 and 10% exclusion zones were also compared. <b><i>Conclusion:</i></b> The ability of BR to track changes in CO is not interchangeable with CO changes as measured by echocardiography. BR, as a trend monitor for changes in CO or SV to determine clinical decisions around interventions in neonatology, should be used with caution.
DOI: 10.5281/zenodo.5159479
title: Replication package for: Forbidden Fruits: The Political Economy of Science, Religion, and Growth

description: The zipped folder contains all the files need to replicate the results reported in the paper “Forbidden Fruits: The Political Economy of Science, Religion, and Growth” by Roland Bénabou, Davide Ticchi, and Andrea Vindigni, published in the Review of Economic Studies.